Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Medtronic’s most recent quarterly results suggest that the medtech monolith could be losing ground to arch-rivals Boston Scientific and St. Jude Medical in the cardiac rhythm management market.
Medtech titan Boston Scientific touts new CE Mark approval to market its WallFlex stent in treatment of narrowed esophagi.
Stryker says it agreed to pay $172 million for Germany’s Berchtold Holding, which makes surgical equipment for operating rooms and ICUs.